Terms: = Small Cell Lung Cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Diagnosis
226 results:
1. ALK fusion small cell transformation of lung adenocarcinoma: A case report and literature review.
Xu G; Zhou L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 49(4):628-636. PubMed ID: 39019792
[TBL] [Abstract] [Full Text] [Related]
2. Berberine synergises with ferroptosis inducer sensitizing NSCLC to ferroptosis in p53-dependent SLC7A11-GPX4 pathway.
Liao W; Zhang R; Chen G; Zhu X; Wu W; Chen Z; Jiang C; Lin Z; Ma L; Yu H
Biomed Pharmacother; 2024 Jul; 176():116832. PubMed ID: 38850659
[TBL] [Abstract] [Full Text] [Related]
3. Non-small cell lung carcinoma with clear cell features: a clinicopathologic, immunohistochemical, and molecular study of 31 cases.
Suster DI; Ronen N; Mejbel HA; Harada S; Mackinnon AC; Suster S
Virchows Arch; 2024 Jul; 485(1):83-96. PubMed ID: 38814477
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer.
Lv M; Li X; Yin Z; Yang H; Zhou B
PLoS One; 2024; 19(4):e0294227. PubMed ID: 38564630
[TBL] [Abstract] [Full Text] [Related]
6. Evolutionary trajectories of small cell lung cancer under therapy.
George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
[TBL] [Abstract] [Full Text] [Related]
7. Next-Generation Sequencing in lung cancers-A Single-Center Experience in Taiwan.
Lai WA; Huang YS; Chang KC; Yang SF; Yang CJ; Liu YW; Chen HD
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399524
[No Abstract] [Full Text] [Related]
8. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
9. Genomic characteristics and immune landscape of super multiple primary lung cancer.
Yang Z; Zhou B; Guo W; Peng Y; Tian H; Xu J; Wang S; Chen X; Hu B; Liu C; Wang Z; Li C; Gao S; He J
EBioMedicine; 2024 Mar; 101():105019. PubMed ID: 38364701
[TBL] [Abstract] [Full Text] [Related]
10. Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors.
Menzel M; Kirchner M; Kluck K; Ball M; Beck S; Allgäuer M; Assmann C; Schnorbach J; Volckmar AL; Tay TKY; Goldschmid H; Tan DS; Thomas M; Kazdal D; Budczies J; Stenzinger A; Christopoulos P
J Pathol Clin Res; 2024 Mar; 10(2):e354. PubMed ID: 38284983
[TBL] [Abstract] [Full Text] [Related]
11. Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives.
Simbolo M; Centonze G; Gkountakos A; Monti V; Maisonneuve P; Golovco S; Sabella G; Del Gobbo A; Gobbo S; Ferrero S; Fabbri A; Pardo C; Garzone G; Prinzi N; Pusceddu S; Testi A; Rolli L; Mangogna A; Bercich L; Benvenuti MR; Bria E; Pilotto S; Berruti A; Pastorino U; Capella C; Infante M; Milella M; Scarpa A; Milione M
Virchows Arch; 2024 May; 484(5):777-788. PubMed ID: 38168015
[TBL] [Abstract] [Full Text] [Related]
12. Whole-exome sequencing explored mechanism of selpercatinib resistance in RET-rearranged lung adenocarcinoma transformation into small-cell lung cancer: a case report.
Peng Y; Zheng Z; Zewen W; Yanan L; Mingyan Z; Meili S
BMC Pulm Med; 2023 Dec; 23(1):492. PubMed ID: 38057798
[TBL] [Abstract] [Full Text] [Related]
13. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms].
Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573
[No Abstract] [Full Text] [Related]
14. Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma.
Yin D; Zhang Y; Li H; Cheng L
Clin Respir J; 2023 Dec; 17(12):1301-1315. PubMed ID: 37985446
[TBL] [Abstract] [Full Text] [Related]
15. Multi-gene Liquid Biopsy to Detect Resistance to First-line Osimertinib in Patients With
Ito S; Tsurumi K; Shindo N; Soma S; Yamaguchi K; Tamai K; Mochizuki M; Fujimori H; Morita M; Watanabe K; Suzuki A; Fukuhara T; Yasuda J
Anticancer Res; 2023 Nov; 43(11):5031-5040. PubMed ID: 37909987
[TBL] [Abstract] [Full Text] [Related]
16. Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases.
Bai K; Chen X; Qi X; Zhang Y; Zou Y; Li J; Yu L; Li Y; Jiang J; Yang Y; Liu Y; Feng S; Bu H
J Neurooncol; 2023 Oct; 165(1):149-160. PubMed ID: 37897649
[TBL] [Abstract] [Full Text] [Related]
17. The XRCC1 and tp53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer.
Karaağaç M; Geredeli Ç; Yıldırım MS; Altınok T; Dede İ; İnal A; Zamani AG; Kaya B; Demirkazık A; Artaç M
J Cancer Res Ther; 2023; 19(5):1248-1254. PubMed ID: 37787291
[TBL] [Abstract] [Full Text] [Related]
18. The Unmet Diagnostic and Treatment Needs in Large cell Neuroendocrine Carcinoma of the lung.
Buium C; Negru S; Ionescu DN; Dediu M
Curr Oncol; 2023 Jul; 30(8):7218-7228. PubMed ID: 37623004
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications.
Seker-Cin H; Tay TKY; Kazdal D; Kluck K; Ball M; Neumann O; Winter H; Herth F; Heußel CP; Savai R; Schirmacher P; Thomas M; Budczies J; Allgäuer M; Christopoulos P; Stenzinger A; Volckmar AL
Lung Cancer; 2023 Oct; 184():107317. PubMed ID: 37586177
[TBL] [Abstract] [Full Text] [Related]
20. The success rates of clinical cancer next-generation sequencing based on pathologic diagnosis: Experience from a single academic laboratory.
Latham K; Dong F
Am J Clin Pathol; 2023 Nov; 160(5):533-539. PubMed ID: 37543867
[TBL] [Abstract] [Full Text] [Related]
[Next]
